Daniel Skubleny

7PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsiesImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
BOLD-100 in Combination with FOLFOX Is a Broadly Effective Therapeutic Strategy for Gastric Cancer.

|Nov 13, 2025
A 107 Gene Nanostring Assay Effectively Translates the Cancer Genome Atlas, and Tumour Microenvironment Gastric Cancer Molecular Classification to a Patient-Derived Organoid Model.

D Skubleny, K Purich, T Williams

|Sep 26, 2024
The Tumor Immune Microenvironment Drives Survival Outcomes and Therapeutic Response in an Integrated Molecular Analysis of Gastric Adenocarcinoma.

Daniel Skubleny, Kieran Purich, David R McLean

|Feb 24, 2024
Individual Survival Distributions Generated by Multi-Task Logistic Regression Yield a New Perspective on Molecular and Clinical Prognostic Factors in Gastric Adenocarcinoma.

Daniel Skubleny, Jennifer Spratlin, Sunita Ghosh

|Jul 18, 2023
Learning Individual Survival Models from PanCancer Whole Transcriptome Data.

Neeraj Kumar, Daniel Skubleny, Michael Parkes

|Jan 21, 2023
Murine and Human Gastric Tissue Establishes Organoids after 48 Hours of Cold Ischemia Time during Shipment.

Daniel Skubleny, Saurabh Garg, Jim Wickware

Pageof 2

Frequent Collaborators

4 joint publications

Gina R Rayat

2 joint publications

Jim Wickware

2 joint publications

Russell Greiner

2 joint publications

Daniel E Schiller